San Francisco Giants right-hander Blade Tidwell saw an increase in opportunities in 2026, but has he done enough to be a part of the team's future plans?

“Giants Talk” hosts Cole Kuiper and Alex Pavlovic discuss Blade Tidwell becoming the fourth pitcher to have Tommy John surgery in 2026.Giants Talk: How should San Francisco address injuries to its pitching staff? originally appeared on NBC Sports Bay Area

The San Francisco Giants acquired Blade Tidwell with the hope that he could be a prized part of their rotation. Now? The questions will take longer to answer.

The San Francisco Giants have another significant pitching injury to deal with. This one comes with a considerable recovery timeline attached. Tidwell’s Diagnosis and Giants’ Surgery Recommendation Blade Tidwell suffered what the team described as a “high-grade sprain” of his UCL. News of the injury surfaced Tuesday. Following a 3-2 loss to the Minnesota Twins, […] The post Giants Hit With Devastating Injury News After Twins Loss appeared first on HEAVY.

Giants manager Tony Vitello speaks to reporters following San Francisco's 3 -2 loss against the Minnesota Twins on Tuesday at Oracle Park. Tony Vitello provides Osleivis Basabe injury update after Giants' loss to Twins originally appeared on NBC Sports Bay Area

Giants manager Tony Vitello speaks to reporters ahead of San Francisco’s matchup against the Minnesota Twins on Tuesday at Oracle Park.Giants manager Tony Vitello didn't see Blade Tidwell's elbow injury coming originally appeared on NBC Sports Bay Area

The San Francisco Giants keep losing pitchers to injuries and now the biggest worry is about Blade Tidwell.

Surgery has been recommended for San Francisco Giants pitcher Blade Tidwell, which would knock the young right-hander out until the 2028 MLB season.

Blade Tidwell will undergo an MRI after leaving with elbow discomfort, creating another major question for the Giants’ depleted 2027 rotation. The post Giants’ Latest Injury Scare Threatens One of Their Few 2027 Answers appeared first on HEAVY.